First-of-its-kind treatment for Acute Lymphoblastic Leukemia developed

Tata Memorial, IDRS Labs develop an oral suspension to be available soon

geetanjali

Geetanjali Minhas | December 29, 2023 | Mumbai


#Health   #Healthcare   #cancer  


Tata Memorial Hospital, Mumbai, the Advanced Centre for Training Research and Education in Cancer (ACTREC), Navi Mumbai along with IDRS Labs, Bangalore have developed an oral suspension of 6-mercaptopurine (6-MP) in India. 6-MP is a chemotherapy drug used in the treatment of acute lymphoblastic leukemia (ALL), the most common type of blood cancer afflicting children.

The first and only child-friendly formulation is available in the form of a powder for oral suspension, and marketed under the tradename ‘PREVALL’.

PREVALL can be reconstituted into 100 ml oral suspension at a concentration of 10mg/ml. It is available with a syringe and a press in bottle adapter (PIBA) for precise dosing tailored to the patient’s body weight or body surface area.

It has been approval by the Central Drugs Standard Control Organization (CDSCO) under the ministry of health and family welfare, government of India. Tata Memorial Centre and IDRS Labs jointly published the results of the clinical study that lead to regulatory approval in the scientific journal Pediatric Blood and Cancer recently.

PREVALL, the dry powder pharmaceutical suspension of 6-mercaptopurine, is a patented technology of IDRS Labs Private Limited and will be available in all major hospital pharmacies across the country very soon. Approximately 10,000 children in the age group of 1-10 years diagnosed with ALL are expected to benefit from PREVALL each year.

Dr. Vikram, Professor of Clinical Pharmacology, ACTREC, said that the powder for oral suspension is designed to ensure stability of the drug in hot/humid conditions and is quite distinct from the liquid formulation available elsewhere in the world.

Dr. Sudeep Gupta, Director, Tata Memorial Centre, Mumbai, said that TMC is committed to fostering innovation, citing the example of CAR-T cell therapy  which was also pioneered by TMC recently in a similar collaborative effort.

Dr. Ajit Kumar Mohanty, Secretary Department of Atomic Energy, and Chairman, Atomic Energy Commission, said the development is an outcome of the convergence of academia and industry interests to bridge the gap between unmet need and innovation in healthcare.
 

Comments

 

Other News

Cabinet approves museum at North-South Block complex

The Cabinet Committee on Economic Affairs, chaired by prime minister Narendra Modi, on Wednesday has approved the development of the Yuge Yugeen Bharat Museum (YYBM) at the North and South Block Complex, New Delhi, at an estimated total project cost of ₹3,230 crore, as appraised by the Public Investmen

Cabinet approves extension of Noida metro corridor

The Union Cabinet, chaired by prime minister Narendra Modi, has approved the extension of Aqua Line Metro Rail Corridor from Noida Sector-51 to Greater Noida Sector-04 of Noida Metro Rail Project with corridor for a length of 8.449 km with 5 elevated stations. On operationalization of this corridor, Noid

India reaffirms commitment to climate multilateralism

India has reaffirmed its commitment to climate multilateralism and the principles of Equity and Common But Differentiated Responsibilities and Respective Capabilities (CBDR-RC), calling for a fair, equitable and ambitious outcome at the 31st Conference of the Parties (COP31) to the United Nations Framewo

How the mind can help the body heal itself

Why do some people recover from illness against all odds? Can our beliefs, emotions and consciousness influence the body’s ability to heal? Drawing on over three decades of experience in medicine, research and medical innovation, internationally trained ophthalmologist and author Dr Dinesh Verma ex

1,364 anti-cancer formulations to cost less from today

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. This was based on the recommendations of an Expert Committee constitute

Who checks the books?

I read about the news about the Coimbatore library over coffee this morning. On the face of it, the headline was about a political ‘war’ between the DMK and TVK. But what stayed with me was something much more important than the blame game behind what had transpired. A writer walking through

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter